Variations in the Antivirulence Effects of Fatty Acids and Virstatin against Vibrio cholerae Strains

키워드

참고문헌 (50)

1. Kanungo S, "Cholera", Lancet, 399, pp.1429~1440 (2022)
2. Clemens JD, "Cholera", Lancet, 390, pp.1539~1549 (2017)
3. Kaper JB, "Cholera", Clin. Microbiol. Rev, 8, pp.48~86 (1995)
4. Safa A, "Evolution of new variants of Vibrio cholerae O1", Trends Microbiol, 18, pp.46~54 (2010)
5. Mutreja A, "Evidence for several waves of global transmission in the seventh cholera pandemic", Nature, 477, pp.462~465 (2011)
6. Kim EJ, "Whole-genome sequence comparisons reveal the evolution of Vibrio cholerae O1", Trends Microbiol, 23, pp.479~489 (2015)
7. Nair GB, "Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh", J. Clin. Microbiol, 44, pp.4211~4213 (2006)
8. Nguyen BM, "Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008", J. Clin. Microbiol, 47, pp.1568~1571 (2009)
9. Childers BM, "Regulation of virulence in Vibrio cholerae : the ToxR regulon", Future Microbiol, 2, pp.335~344 (2007)
10. Hsiao A, "Pathogenicity and virulence regulation of Vibrio cholerae at the interface of host-gut microbiome interactions", Virulence, 11, pp.1582~1599 (2020)
11. Li J, "Vibrio cholerae toxin-coregulated pilus structure analyzed by hydrogen", deuterium exchange mass spectrometry, 2008, pp.16, 137~148
12. Waldor MK, "Lysogenic conversion by a filamentous phage encoding cholera toxin", Science, 272, pp.1910~1914 (1996)
13. DiRita VJ, "Differential expression of the ToxR regulon in classical and E1 Tor biotypes of Vibrio cholerae is due to biotype-specific control over toxT expression", Proc. Natl. Acad. Sci. USA, 93, pp.7991~7995 (1996)
14. Naha A, "Elucidating the correlation between the number of TTTTGAT heptamer repeats and cholera toxin promoter activity in Vibrio cholerae O1 pandemic strains", FEMS Microbiol. Lett, 369, pp.fnac041~ (2022)
15. Yu RR, "Regulation of gene expression in Vibrio cholerae by ToxT involves both antirepression and RNA polymerase stimulation", Mol. Microbiol, 43, pp.119~134 (2002)
16. Miller VL, "Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR", Proc. Natl. Acad. Sci. USA, 81, pp.3471~3475 (1984)
17. Withey JH, "The toxbox : specific DNA sequence requirements for activation of Vibrio cholerae virulence genes by ToxT", Mol. Microbiol, 59, pp.1779~1789 (2006)
18. Waldor MK, "A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139", J. Bacteriol, 178, pp.4157~4165 (1996)
19. Sanchez J, "Expression of cholera toxin under non-AKI conditions in Vibrio cholerae El Tor induced by increasing the exposed surface of cultures", J. Bacteriol, 186, pp.1355~1361 (2004)
20. Iwanaga M, "Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor", Microbiol. Immunol, 30, pp.1075~1083 (1986)
21. Baek Y, "Cholera toxin production in Vibrio cholerae O1 El Tor biotype strains in single-phase culture", Front. Microbiol, 11, pp.825~ (2020)
22. Lee D, "Expression of cholera toxin(CT)and the toxin co-regulated pilus(TCP)by variants of ToxT in Vibrio cholerae strains", Toxins(Basel), 15, pp.507~ (2023)
23. Choi H, "Intracellular expression of CTB in Vibrio cholerae strains in laboratory culture conditions", J. Microbiol. Biotechnol, 33, pp.736~744 (2023)
24. Kim EJ, "Inactivated Vibrio cholerae strains that express TcpA via the toxT-139F allele induce antibody responses against TcpA", J. Microbiol. Biotechnol, 32, pp.1396~1405 (2022)
25. Hung DT, "Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization", Science, 310, pp.670~674 (2005)
26. Anthouard R, "Small-molecule inhibitors of toxT expression in Vibrio cholerae", mBio, 4, pp.e00403-13~ (2013)
27. Woodbrey AK, "A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT", Sci. Rep, 7, pp.45011~ (2017)
28. Chatterjee A, "Effect of fatty acids and cholesterol present in bile on expression of virulence factors and motility of Vibrio cholerae", Infect. Immun, 75, pp.1946~1953 (2007)
29. Withey JH, "Conjugated linoleic acid reduces cholera toxin production in vitro and in vivo by inhibiting Vibrio cholerae ToxT activity", Antimicrob. Agents Chemother, 59, pp.7471~7476 (2015)
30. Lowden MJ, "Structure of Vibrio cholerae ToxT reveals a mechanism for fatty acid regulation of virulence genes", Proc. Natl. Acad. Sci. USA, 107, pp.2860~2865 (2010)
31. Shakhnovich EA, "Virstatin inhibits dimerization of the transcriptional activator ToxT", Proc. Natl. Acad. Sci. USA, 104, pp.2372~2377 (2007)
32. Cruite JT, "Structural basis for virulence regulation in Vibrio cholerae by unsaturated fatty acid components of bile", Commun. Biol, 2, pp.440~ (2019)
33. Kim EJ, "Molecular insights into the evolutionary pathway of Vibrio cholerae O1atypical El Tor variants", PLoS Pathog, 10, pp.e1004384~ (2014)
34. Kim EJ, "Replication of Vibrio cholerae classical CTX phage", Proc. Natl. Acad. Sci. USA, 114, pp.2343~2348 (2017)
35. Plecha SC, "Mechanism for inhibition of Vibrio cholerae ToxT activity by the unsaturated fatty acid components of bile", J. Bacteriol, 197, pp.1716~1725 (2015)
36. Lagos R, "Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O", Infect. Immun, 63, pp.707~709 (1995)
37. Lee D, "Alterations in glucose metabolism in Vibrio cholerae serogroup O1 El Tor biotype strains", Sci. Rep, 10, pp.308~ (2020)
38. Chin CS, "The origin of the Haitian cholera outbreak strain", N. Engl. J. Med, 364, pp.33~42 (2011)
39. Satchell KJ, "Phenotypic analysis reveals that the 2010 Haiti cholera epidemic is linked to a hypervirulent strain", Infect. Immun, 84, pp.2473~2481 (2016)
40. Jonson G, "Expression of virulence factors by classical and El Tor Vibrio cholerae in vivo and in vitro", FEMS Microbiol. Lett, 74, pp.221~228 (1990)
41. D'Mello-Guyett L, "Prevention and control of cholera with household and community water, sanitation and hygiene(WASH)interventions : a scoping review of current international guidelines", PLoS One, 15, pp.e0226549~ (2020)
42. Shaikh H, "Current and future cholera vaccines", Vaccine 38 Suppl, 1, pp.A118~A126 (2020)
43. Sit B, "Emerging concepts in cholera vaccine design", Ann. Rev. Microbiol, 76, pp.681~702 (2022)
44. Chowdhury F, "A phase I", II study to evaluate safety, tolerability and immunogenicity of Hillchol(R), an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh, 2021, pp.39, 4450~4457
45. Clatworthy AE, "Targeting virulence : a new paradigm for antimicrobial therapy", Nat. Chem. Biol, 3, pp.541~548 (2007)
46. Sarveswari HB, "Development of a smart pH-responsive nano-polymer drug, 2-methoxy-4-vinylphenol conjugate against the intestinal pathogen, Vibrio cholerae", Sci. Rep, 13, pp.1250~ (2023)
47. Childers BM, "N-terminal residues of the Vibrio cholerae virulence regulatory protein ToxT involved in dimerization and modulation by fatty acids", J. Biol. Chem, 286, pp.28644~28655 (2011)
48. Taylor RK, "A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure", Infect. Immun, 72, pp.6050~6060 (2004)
49. Heidelberg JF, "DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae", Nature, 406, pp.477~483 (2000)
50. Faruque SM, "Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage", Proc. Natl. Acad. Sci. USA, 104, pp.5151~5156 (2007)

관련 논문AI추천